Education
About Us
Working with TipRanks
Follow Us
Aoxing Pharma (AOXG)
:AOXG
Total Valuation
Aoxing Pharmaceutical Company has a market cap or net worth of $701.12K. The enterprise value is $0.00.
Market Cap$701.12K
Enterprise Value$0.00
Share Statistics
Aoxing Pharmaceutical Company has 76,209,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding76,209,000
Owned by Insiders―
Owned by Institutions0.04%
Financial Efficiency
Aoxing Pharmaceutical Company’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)0.00
Return on Assets (ROA)0.00
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee0.00
Employee Count346
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aoxing Pharmaceutical Company is 0.00. Aoxing Pharmaceutical Company’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, Aoxing Pharmaceutical Company had revenue of 0.00 and earned 0.00 in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income0.00
Net Income0.00
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.36M and capital expenditures -30.27K, giving a free cash flow of -1.39M billion.
Operating Cash Flow-1.36M
Free Cash Flow-1.39M
Free Cash Flow per Share-0.02
Dividends & Yields
Aoxing Pharmaceutical Company pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.84
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average―
Relative Strength Index (RSI)44.75
Average Volume (3m)107.29K
Important Dates
Aoxing Pharmaceutical Company upcoming earnings date is May 15, 2017, TBA Not Confirmed.
Last Earnings DateInvalid Date
Next Earnings DateMay 15, 2017
Ex-Dividend Date―
Financial Position
Aoxing Pharmaceutical Company as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
Current Ratio0.00
Quick Ratio0.00
Debt to Market Cap0.00
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aoxing Pharmaceutical Company has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aoxing Pharmaceutical Company EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Aoxing Pharmaceutical Company has $7.08M in cash and marketable securities with $27.72M in debt, giving a net cash position of $20.64M billion.
Cash & Marketable Securities$7.08M
Total Debt$27.72M
Net Cash$20.64M
Net Cash Per Share$0.27
Tangible Book Value Per Share$0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aoxing Pharmaceutical Company is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―